# DANA Inc: financial statements, quarterly

DAN · NYSE · CIK 26780 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/dan.md) · [Financials](/companies/dan/financials.md) · [Filings](/companies/dan/filings.md) · [Insiders](/companies/dan/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dan/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,669](/filings/0001437749-24-032558.md) | [(448) d](/filings/0001437749-26-006076.md) | [2,015](/filings/0001437749-26-006076.md) | [2,047](/filings/0001437749-26-006076.md) | [1,897](/filings/0001437749-26-006076.md) | [1,775](/filings/0001437749-26-006076.md) | [1,781](/filings/0001437749-26-017296.md) | [1,935](/filings/0001437749-26-026123.md) | [1,917](/filings/0001437749-26-006076.md) | [1,867](/filings/0001437749-26-006076.md) | [1,868](/filings/0001437749-26-017296.md) | [2,010](/filings/0001437749-26-026123.md) |
| Cost of revenue | $m | [2,433](/filings/0001437749-24-032558.md) | [(89.0) d](/filings/0001437749-26-006076.md) | [1,903](/filings/0001437749-26-006076.md) | [1,930](/filings/0001437749-26-006076.md) | [1,775](/filings/0001437749-26-006076.md) | [1,748](/filings/0001437749-26-006076.md) | [1,663](/filings/0001437749-26-017296.md) | [1,797](/filings/0001437749-26-026123.md) | [1,751](/filings/0001437749-26-006076.md) | [1,687](/filings/0001437749-26-006076.md) | [1,699](/filings/0001437749-26-017296.md) | [1,800](/filings/0001437749-26-026123.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [126](/filings/0001437749-24-032558.md) | [30.0 d](/filings/0001437749-26-006076.md) | [139](/filings/0001437749-25-013716.md) | [108](/filings/0001437749-25-025910.md) | [106](/filings/0001437749-25-032594.md) | [101 d](/filings/0001437749-26-006076.md) | [105](/filings/0001437749-26-017296.md) | [99.0](/filings/0001437749-26-026123.md) | [87.0](/filings/0001437749-25-032594.md) | [96.0 d](/filings/0001437749-26-006076.md) | [102](/filings/0001437749-26-017296.md) | [104](/filings/0001437749-26-026123.md) |
| Operating income | $m | [91.0](/filings/0001437749-24-032558.md) | [(413) d](/filings/0001437749-26-006076.md) | [70.0](/filings/0001437749-25-013716.md) | [(13.0)](/filings/0001437749-25-025910.md) | [(8.0)](/filings/0001437749-25-032594.md) | [(117) d](/filings/0001437749-26-006076.md) | [8.0](/filings/0001437749-26-017296.md) | [16.0](/filings/0001437749-26-026123.md) | [53.0](/filings/0001437749-25-032594.md) | [62.0 d](/filings/0001437749-26-006076.md) | [19.0](/filings/0001437749-26-017296.md) | [76.0](/filings/0001437749-26-026123.md) |
| Interest expense | $m | [41.0](/filings/0001437749-24-032558.md) | [38.0 d](/filings/0001437749-26-006076.md) | [39.0](/filings/0001437749-25-013716.md) | [40.0](/filings/0001437749-25-025910.md) | [38.0](/filings/0001437749-25-032594.md) | [41.0 d](/filings/0001437749-26-006076.md) | [39.0](/filings/0001437749-26-017296.md) | [44.0](/filings/0001437749-26-026123.md) | [47.0](/filings/0001437749-25-032594.md) | [51.0 d](/filings/0001437749-26-006076.md) | [22.0](/filings/0001437749-26-017296.md) | [21.0](/filings/0001437749-26-026123.md) |
| Income tax | $m | [33.0](/filings/0001437749-24-032558.md) | [(111) d](/filings/0001437749-26-006076.md) | [37.0](/filings/0001437749-25-013716.md) | [12.0](/filings/0001437749-25-025910.md) | [(18.0)](/filings/0001437749-25-032594.md) | [44.0 d](/filings/0001437749-26-006076.md) | [(10.0)](/filings/0001437749-26-017296.md) | [10.0](/filings/0001437749-26-026123.md) | [(2.0)](/filings/0001437749-25-032594.md) | [55.0 d](/filings/0001437749-26-006076.md) | [14.0](/filings/0001437749-26-017296.md) | [54.0](/filings/0001437749-26-026123.md) |
| Net income | $m | [19.0](/filings/0001437749-24-032558.md) | [(39.0) d](/filings/0001437749-26-006076.md) | [3.0](/filings/0001437749-26-006076.md) | [16.0](/filings/0001437749-26-006076.md) | [4.0](/filings/0001437749-26-006076.md) | [(80.0)](/filings/0001437749-26-006076.md) | [25.0](/filings/0001437749-26-017296.md) | [27.0](/filings/0001437749-26-026123.md) | [83.0](/filings/0001437749-26-006076.md) | [(50.0)](/filings/0001437749-26-006076.md) | [1,087](/filings/0001437749-26-017296.md) | [(5.0)](/filings/0001437749-26-026123.md) |
| Diluted EPS | $ per share | [0.13](/filings/0001437749-24-032558.md) | not reported | [0.02](/filings/0001437749-26-006076.md) | [0.11](/filings/0001437749-26-006076.md) | [0.03](/filings/0001437749-26-006076.md) | [(0.55)](/filings/0001437749-26-006076.md) | [0.17](/filings/0001437749-26-017296.md) | [0.19](/filings/0001437749-26-026123.md) | [0.64](/filings/0001437749-26-006076.md) | [(0.43)](/filings/0001437749-26-006076.md) | [9.89](/filings/0001437749-26-017296.md) | [(0.05)](/filings/0001437749-26-026123.md) |
| Basic EPS | $ per share | [0.13](/filings/0001437749-24-032558.md) | not reported | [0.02](/filings/0001437749-26-006076.md) | [0.11](/filings/0001437749-26-006076.md) | [0.03](/filings/0001437749-26-006076.md) | [(0.55)](/filings/0001437749-26-006076.md) | [0.17](/filings/0001437749-26-017296.md) | [0.19](/filings/0001437749-26-026123.md) | [0.65](/filings/0001437749-26-006076.md) | [(0.43)](/filings/0001437749-26-006076.md) | [9.89](/filings/0001437749-26-017296.md) | [(0.05)](/filings/0001437749-26-026123.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [421](/filings/0001437749-24-032558.md) | [529](/filings/0001437749-26-006076.md) | [351](/filings/0001437749-25-013716.md) | [419](/filings/0001437749-25-025910.md) | [419](/filings/0001437749-25-032594.md) | [494](/filings/0001437749-26-026123.md) | [507](/filings/0001437749-26-017296.md) | [486](/filings/0001437749-26-026123.md) | [414](/filings/0001437749-25-032594.md) | [469](/filings/0001437749-26-026123.md) | [477](/filings/0001437749-26-017296.md) | [331](/filings/0001437749-26-026123.md) |
| Current assets | $m | [4,220](/filings/0001437749-23-029169.md) | [4,103](/filings/0001437749-25-004554.md) | [4,102](/filings/0001437749-24-013892.md) | [4,076](/filings/0001437749-24-024009.md) | [4,054](/filings/0001437749-24-032558.md) | [3,704](/filings/0001437749-26-006076.md) | [4,031](/filings/0001437749-25-013716.md) | [4,187](/filings/0001437749-25-025910.md) | [4,129](/filings/0001437749-25-032594.md) | [3,868](/filings/0001437749-26-026123.md) | [3,239](/filings/0001437749-26-017296.md) | [3,205](/filings/0001437749-26-026123.md) |
| Total assets | $m | [7,937](/filings/0001437749-23-029169.md) | [7,948](/filings/0001437749-26-006076.md) | [7,857](/filings/0001437749-25-013716.md) | [7,808](/filings/0001437749-24-024009.md) | [7,859](/filings/0001437749-24-032558.md) | [7,486](/filings/0001437749-26-006076.md) | [7,800](/filings/0001437749-25-013716.md) | [8,139](/filings/0001437749-25-025910.md) | [8,108](/filings/0001437749-25-032594.md) | [7,808](/filings/0001437749-26-026123.md) | [6,078](/filings/0001437749-26-017296.md) | [6,113](/filings/0001437749-26-026123.md) |
| Current liabilities | $m | [2,670](/filings/0001437749-23-029169.md) | [2,602](/filings/0001437749-25-004554.md) | [2,565](/filings/0001437749-24-013892.md) | [2,758](/filings/0001437749-24-024009.md) | [2,716](/filings/0001437749-24-032558.md) | [2,561](/filings/0001437749-26-006076.md) | [2,828](/filings/0001437749-25-013716.md) | [3,070](/filings/0001437749-25-025910.md) | [3,158](/filings/0001437749-25-032594.md) | [3,308](/filings/0001437749-26-026123.md) | [2,068](/filings/0001437749-26-017296.md) | [2,156](/filings/0001437749-26-026123.md) |
| Total liabilities | $m | [6,080](/filings/0001437749-23-029169.md) | [6,137](/filings/0001437749-25-004554.md) | [6,056](/filings/0001437749-24-013892.md) | [6,059](/filings/0001437749-24-024009.md) | [6,111](/filings/0001437749-24-032558.md) | [5,901](/filings/0001437749-26-006076.md) | [6,165](/filings/0001437749-25-013716.md) | [6,680](/filings/0001437749-25-025910.md) | [6,770](/filings/0001437749-25-032594.md) | [6,909](/filings/0001437749-26-026123.md) | [4,064](/filings/0001437749-26-017296.md) | [4,130](/filings/0001437749-26-026123.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [37.0](/filings/0001437749-23-029169.md) | [22.0](/filings/0001437749-25-004554.md) | [39.0](/filings/0001437749-24-013892.md) | [19.0](/filings/0001437749-24-024009.md) | [23.0](/filings/0001437749-24-032558.md) | [8.0](/filings/0001437749-26-006076.md) | [130](/filings/0001437749-25-013716.md) | [530](/filings/0001437749-25-025910.md) | [630](/filings/0001437749-25-032594.md) | [615](/filings/0001437749-26-026123.md) | [0.0](/filings/0001437749-26-017296.md) | [0.0](/filings/0001437749-26-026123.md) |
| Shareholders' equity | $m | [1,589](/filings/0001437749-23-029169.md) | [1,575](/filings/0001437749-25-004554.md) | [1,539](/filings/0001437749-24-013892.md) | [1,475](/filings/0001437749-24-024009.md) | [1,480](/filings/0001437749-24-032558.md) | [1,333](/filings/0001437749-26-006076.md) | [1,379](/filings/0001437749-25-013716.md) | [1,204](/filings/0001437749-25-025910.md) | [1,093](/filings/0001437749-25-032594.md) | [840](/filings/0001437749-26-026123.md) | [1,955](/filings/0001437749-26-017296.md) | [1,920](/filings/0001437749-26-026123.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [112 d](/filings/0001437749-24-032558.md) | [278 d](/filings/0001437749-26-006076.md) | [(102)](/filings/0001437749-25-013716.md) | [215 d](/filings/0001437749-25-025910.md) | [35.0 d](/filings/0001437749-25-032594.md) | [302 d](/filings/0001437749-26-006076.md) | [(37.0)](/filings/0001437749-26-017296.md) | [32.0 d](/filings/0001437749-26-026123.md) | [111 d](/filings/0001437749-25-032594.md) | [406 d](/filings/0001437749-26-006076.md) | [(195)](/filings/0001437749-26-017296.md) | [109 d](/filings/0001437749-26-026123.md) |
| Capital expenditure | $m | [117 d](/filings/0001437749-24-032558.md) | [68.0 d](/filings/0001437749-26-006076.md) | [70.0](/filings/0001437749-25-013716.md) | [91.0 d](/filings/0001437749-25-025910.md) | [37.0 d](/filings/0001437749-25-032594.md) | [114 d](/filings/0001437749-26-006076.md) | [67.0](/filings/0001437749-26-017296.md) | [37.0 d](/filings/0001437749-26-026123.md) | [49.0 d](/filings/0001437749-25-032594.md) | [61.0 d](/filings/0001437749-26-006076.md) | [62.0](/filings/0001437749-26-017296.md) | [142 d](/filings/0001437749-26-026123.md) |
| Dividends paid | $m | [14.0 d](/filings/0001437749-24-032558.md) | [15.0 d](/filings/0001437749-26-006076.md) | [15.0](/filings/0001437749-25-013716.md) | [14.0 d](/filings/0001437749-25-025910.md) | [14.0 d](/filings/0001437749-25-032594.md) | [15.0 d](/filings/0001437749-26-006076.md) | [15.0](/filings/0001437749-26-017296.md) | [14.0 d](/filings/0001437749-26-026123.md) | [13.0 d](/filings/0001437749-25-032594.md) | [12.0 d](/filings/0001437749-26-006076.md) | [13.0](/filings/0001437749-26-017296.md) | [13.0 d](/filings/0001437749-26-026123.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [182 d](/filings/0001437749-25-032594.md) | [211 d](/filings/0001437749-26-006076.md) | [125](/filings/0001437749-26-017296.md) | [44.0 d](/filings/0001437749-26-026123.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [144](/filings/0001437749-24-024009.md) | [145](/filings/0001437749-24-032558.md) | [145](/filings/0001437749-26-006076.md) | [145](/filings/0001437749-26-006076.md) | [145](/filings/0001437749-26-006076.md) | [145](/filings/0001437749-26-006076.md) | [146](/filings/0001437749-26-017296.md) | [144](/filings/0001437749-26-026123.md) | [131](/filings/0001437749-26-006076.md) | [116](/filings/0001437749-26-006076.md) | [110](/filings/0001437749-26-017296.md) | [110](/filings/0001437749-26-026123.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 107,576,679 at 2026-07-17, from the cover of the [10-Q filed 2026-08-06](/filings/0001437749-26-026123.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:18 ET. No prices; not investment advice.
